Hosted on MSN

Guangzhou Innogen updates corporate articles following H share listing

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H ( (HK:2591)) has issued an announcement. Guangzhou Innogen Pharmaceutical Group Co., Ltd has announced amendments to its Articles of Association ...
Hosted on MSN

Guangzhou Innogen’s efsubaglutide alfa gains national reimbursement approval

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Reuters

China's Innogen expects to complete weight-loss drug trials next year

SHANGHAI, July 1 (Reuters) - Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next year, its CEO said on Tuesday, the latest ...
Wall Street Journal

Guangzhou Innogen Pharmaceutical Group Co. Ltd.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...